Coenzyme Q
Humans
Adenosine Triphosphate
Cadherins
/ genetics
Cell Line, Tumor
Hypoxia-Inducible Factor 1, alpha Subunit
/ genetics
Inflammasomes
Inflammation
Interleukin-18
Lactate Dehydrogenase 5
Lactates
Lipopolysaccharides
NLR Family, Pyrin Domain-Containing 3 Protein
/ genetics
Triple Negative Breast Neoplasms
/ genetics
Ubiquinone
/ pharmacology
CoQ0
EMT
HIF-1α
NLRP3 inflammasome
Warburg effects
Journal
Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
29
11
2022
accepted:
02
02
2023
pubmed:
28
2
2023
medline:
22
3
2023
entrez:
27
2
2023
Statut:
ppublish
Résumé
Coenzyme Q
Identifiants
pubmed: 36847822
doi: 10.1007/s00204-023-03456-w
pii: 10.1007/s00204-023-03456-w
doi:
Substances chimiques
Adenosine Triphosphate
8L70Q75FXE
Cadherins
0
cobaltous chloride
EVS87XF13W
Hypoxia-Inducible Factor 1, alpha Subunit
0
Inflammasomes
0
Interleukin-18
0
Lactate Dehydrogenase 5
EC 1.1.1.27.-
Lactates
0
Lipopolysaccharides
0
NLR Family, Pyrin Domain-Containing 3 Protein
0
Ubiquinone
1339-63-5
NLRP3 protein, human
0
HIF1A protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1047-1068Subventions
Organisme : Ministry of Science and Technology, Taiwan
ID : MOST-109-2320-B-039-057-MY3
Organisme : Ministry of Science and Technology, Taiwan
ID : MOST-110-2320-B-039-046-MY3
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Armstrong JS, Whiteman M, Rose P, Jones DP (2003) The coenzyme Q
pubmed: 12949071
doi: 10.1074/jbc.M307841200
Balamurugan K (2016) HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer 138(5):1058–1066
pubmed: 25784597
doi: 10.1002/ijc.29519
Barriga EH, Maxwell PH, Reyes AE, Mayor R (2013) The hypoxia factor Hif-1α controls neural crest chemotaxis and epithelial to mesenchymal transition. J Cell Biol 201(5):759–776
pubmed: 23712262
pmcid: 3664719
doi: 10.1083/jcb.201212100
Broz P, Monack DM (2011) Molecular mechanisms of inflammasome activation during microbial infections. Immunol Rev 243(1):174–190
pubmed: 21884176
pmcid: 3170129
doi: 10.1111/j.1600-065X.2011.01041.x
Courtnay R, Ngo DC, Malik N, Ververis K, Tortorella SM, Karagiannis TC (2015) Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep 42(4):841–851
pubmed: 25689954
doi: 10.1007/s11033-015-3858-x
Fink SL, Cookson BT (2005) Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 73(4):1907–1916
pubmed: 15784530
pmcid: 1087413
doi: 10.1128/IAI.73.4.1907-1916.2005
Ganapathy-Kanniappan S (2018) Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype. Crit Rev Biochem Mol Biol 53(6):667–682
pubmed: 30668176
doi: 10.1080/10409238.2018.1556578
Geethangili M, Tzeng Y-M (2011) Review of pharmacological effects of Antrodia camphorata and its bioactive compounds. Evid Based Complement Altern Med. https://doi.org/10.1093/ecam/nep108
doi: 10.1093/ecam/nep108
Ghuwalewala S, Ghatak D, Das P et al (2016) CD44
pubmed: 26926234
doi: 10.1016/j.scr.2016.02.028
Grebe A, Hoss F, Latz E (2018) NLRP3 inflammasome and the IL-1 pathway in atherosclerosis. Circ Res 122(12):1722–1740
pubmed: 29880500
doi: 10.1161/CIRCRESAHA.118.311362
Hamarsheh S, Zeiser R (2020) NLRP3 inflammasome activation in cancer: a double-edged sword. Front Immunol 11:1444
pubmed: 32733479
pmcid: 7360837
doi: 10.3389/fimmu.2020.01444
Ho M-L, Hsiao Y-H, Su S-Y, Chou M-C, Liaw Y-P (2015) Mortality of breast cancer in Taiwan, 1971–2010: Temporal changes and an age–period–cohort analysis. J Obstet Gynaecol 35(1):60–63
pubmed: 25020211
doi: 10.3109/01443615.2014.935717
Hseu Y-C, Yang H-L, Lai Y-C, Lin J-G, Chen G-W, Chang Y-H (2004) Induction of apoptosis by Antrodia camphorata in human premyelocytic leukemia HL-60 cells. Nutr Cancer 48(2):189–197
pubmed: 15231454
doi: 10.1207/s15327914nc4802_9
Hseu Y-C, Chen S-C, Tsai P-C et al (2007) Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogen-nonresponsive breast cancer cells by Antrodia camphorata. Food Chem Toxicol 45(7):1107–1115
pubmed: 17391824
doi: 10.1016/j.fct.2006.12.012
Hseu Y-C, Huang H-C, Hsiang C-Y (2010) Antrodia camphorata suppresses lipopolysaccharide-induced nuclear factor-κB activation in transgenic mice evaluated by bioluminescence imaging. Food Chem Toxicol 48(8–9):2319–2325
pubmed: 20621584
doi: 10.1016/j.fct.2010.05.066
Hseu Y-C, Thiyagarajan V, Tsou H-T et al (2016) In vitro and in vivo anti-tumor activity of CoQ
pubmed: 26968952
pmcid: 5008369
doi: 10.18632/oncotarget.7983
Hseu Y-C, Chao Y-H, Lin K-Y et al (2017) Antrodia camphorata inhibits metastasis and epithelial-to-mesenchymal transition via the modulation of claudin-1 and Wnt/β-catenin signaling pathways in human colon cancer cells. J Ethnopharmacol 208:72–83
pubmed: 28688953
doi: 10.1016/j.jep.2017.07.001
Hseu YC, Tseng YF, Pandey S, Shrestha S, Lin KY, Lin CW, Lee CC, Huang ST, Yang HL (2022) Coenzyme Q0 inhibits NLRP3 inflammasome activation through mitophagy induction in LPS/ATP-stimulated macrophages. Oxid Med Cell Longev. 2022:4266214. https://doi.org/10.1155/2022/4266214
doi: 10.1155/2022/4266214
pubmed: 35035661
pmcid: 8759827
Hughes MM, O’Neill LA (2018) Metabolic regulation of nlrp 3. Immunol Rev 281(1):88–98
pubmed: 29247992
doi: 10.1111/imr.12608
Iqbal MA, Chattopadhyay S, Siddiqui FA et al (2021) Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications. FEBS J 288(2):471–485
pubmed: 32356386
doi: 10.1111/febs.15353
Jia J, Liu Y, Zhang X, Liu X, Qi J (2013) Regulation of iNOS expression by NF-κB in human lens epithelial cells treated with high levels of glucose. Invest Ophthalmol vis Sci 54(7):5070–5077
pubmed: 23812491
doi: 10.1167/iovs.13-11796
Jin J, Qiu S, Wang P et al (2019) Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming. J Exp Clin Cancer Res 38(1):1–16
doi: 10.1186/s13046-019-1351-4
Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Investig 119(6):1420–1428
pubmed: 19487818
pmcid: 2689101
doi: 10.1172/JCI39104
Kawasaki T, Kawai T (2014) Toll-like receptor signaling pathways. Front Immunol. https://doi.org/10.3389/fimmu.2014.00461
doi: 10.3389/fimmu.2014.00461
pubmed: 25309543
pmcid: 4174766
Khan A, Siddiqui S, Husain SA, Mazurek S, Iqbal MA (2021) Phytocompounds targeting metabolic reprogramming in cancer: an assessment of role, mechanisms, pathways, and therapeutic relevance. J Agric Food Chem 69(25):6897–6928
doi: 10.1021/acs.jafc.1c01173
Klück V, Tim L, Janssen M et al (2020) Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol 2(5):e270–e280
pubmed: 33005902
pmcid: 7523621
doi: 10.1016/S2665-9913(20)30065-5
Knudsen CA, Tappel AL, North JA (1996) Multiple antioxidants protect against heme protein and lipid oxidation in kidney tissue. Free Radical Biol Med 20(2):165–173
doi: 10.1016/0891-5849(95)02027-6
Kumar Jha M, Jeon S, Suk K (2012) Pyruvate dehydrogenase kinases in the nervous system: their principal functions in neuronal-glial metabolic interaction and neuro-metabolic disorders. Curr Neuropharmacol 10(4):393–403
doi: 10.2174/157015912804499528
Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. Nat Rev Immunol 13(6):397–411
pubmed: 23702978
doi: 10.1038/nri3452
Lee HE, Lee JY, Yang G et al (2019) Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells. Sci Rep 9(1):1–9
Li Q, Mattingly RR (2008) Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells. Neoplasia 10(12):1444–1458
pubmed: 19048123
pmcid: 2586695
doi: 10.1593/neo.08968
Li S, Pritchard DM, Yu L-G (2022a) Regulation and function of matrix metalloproteinase-13 in cancer progression and metastasis. Cancers 14(13):3263
pubmed: 35805035
pmcid: 9265061
doi: 10.3390/cancers14133263
Li Z, Xia Z, Yu Y et al (2022b) A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma. BMC Med Genom 15(1):1–17
doi: 10.1186/s12920-022-01339-0
Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2(2):329–333. https://doi.org/10.1038/nprot.2007.30
doi: 10.1038/nprot.2007.30
pubmed: 17406593
Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41(3):211–218
pubmed: 26778478
pmcid: 4783224
doi: 10.1016/j.tibs.2015.12.001
Lu H, Lyu Y, Tran L et al (2021) HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells. Cell Rep 36(13):109757
pubmed: 34592152
doi: 10.1016/j.celrep.2021.109757
MacDonald MJ, Husain RD, Hoffmann-Benning S, Baker TR (2004) Immunochemical identification of coenzyme Q
pubmed: 15075342
doi: 10.1074/jbc.M314148200
Marandi Y, Hashemzade S, Tayebinia H, Karimi J, Zamani A, Khodadadi I (2021) NLRP3-inflammasome activation is associated with epithelial-mesenchymal transition and progression of colorectal cancer. Iran J Basic Med Sci 24(4):483
pubmed: 34094030
pmcid: 8143712
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63
pubmed: 6606682
doi: 10.1016/0022-1759(83)90303-4
Mrozik KM, Blaschuk OW, Cheong CM, Zannettino ACW, Vandyke K (2018) N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer. BMC Cancer 18(1):1–16
doi: 10.1186/s12885-018-4845-0
Nagao A, Kobayashi M, Koyasu S, Chow CC, Harada H (2019) HIF-1-dependent reprogramming of glucose metabolic pathway of cancer cells and its therapeutic significance. Int J Mol Sci 20(2):238
pubmed: 30634433
pmcid: 6359724
doi: 10.3390/ijms20020238
Nakamura M, Tokura Y (2011) Epithelial–mesenchymal transition in the skin. J Dermatol Sci 61(1):7–13
pubmed: 21167690
doi: 10.1016/j.jdermsci.2010.11.015
Nikonovas T, Spessa A, Doerr SH, Clay GD, Mezbahuddin S (2020) Near-complete loss of fire-resistant primary tropical forest cover in Sumatra and Kalimantan. Commun Earth Environ 1(1):1–8
doi: 10.1038/s43247-020-00069-4
Oh YS, Kim HY, Song I-C et al (2012) Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α. Oncol Rep 28(6):2239–2246
pubmed: 23023480
doi: 10.3892/or.2012.2063
Ramos Solis N, Yeh ES (2022) HUNK regulation of interleukin 4 in triple negative breast cancer. FASEB J. https://doi.org/10.1096/fasebj.2022.36.S1.R2558
doi: 10.1096/fasebj.2022.36.S1.R2558
Rana NK, Singh P, Koch B (2019) CoCl2 simulated hypoxia induce cell proliferation and alter the expression pattern of hypoxia associated genes involved in angiogenesis and apoptosis. Biol Res 52(1):1–13
doi: 10.1186/s40659-019-0221-z
Shibata S, Sogabe S, Miwa M et al (2021) Identification of the first highly selective inhibitor of human lactate dehydrogenase B. Sci Rep 11(1):1–12
doi: 10.1038/s41598-021-00820-7
Sibiak R, Ozegowska K, Wender-Ozegowska E, Gutaj P, Mozdziak P, Kempisty B (2022) Fetomaternal expression of glucose transporters (GLUTs). Biochem Cell Clin Aspects 14(10):2025
Siddiqui FA, Prakasam G, Chattopadhyay S et al (2018) Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition. Sci Rep 8(1):1–9
doi: 10.1038/s41598-018-25524-3
Sun Q, Scott MJ (2016) Caspase-1 as a multifunctional inflammatory mediator: noncytokine maturation roles. J Leukoc Biol 100(5):961–967
pubmed: 27450556
pmcid: 6608062
doi: 10.1189/jlb.3MR0516-224R
Sun X, Wang M, Wang M et al (2020) Metabolic reprogramming in triple-negative breast cancer. Front Oncol 10:428
pubmed: 32296646
pmcid: 7136496
doi: 10.3389/fonc.2020.00428
Tomita H, Tanaka K, Tanaka T (2016) Hara A Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget 7:11018–11032
pubmed: 26783961
pmcid: 4905455
doi: 10.18632/oncotarget.6920
Vadivalagan C, Krishnan A, Chen S-J et al (2022) The Warburg effect in osteoporosis: cellular signaling and epigenetic regulation of energy metabolic events to targeting the osteocalcin for phenotypic alteration. Cell Signal 100:110488
pubmed: 36208706
doi: 10.1016/j.cellsig.2022.110488
Walsh EM, Keane MM, Wink DA, Callagy G, Glynn SA (2016) Review of triple negative breast cancer and the impact of inducible nitric oxide synthase on tumor biology and patient outcomes. Crit Rev Oncog 21(5–6):333
pubmed: 29431082
pmcid: 6353632
doi: 10.1615/CritRevOncog.2017021307
Wang H-M, Yang H-L, Thiyagarajan V et al (2017) Coenzyme Q
pubmed: 27821721
doi: 10.1177/1534735416673907
Wang S, Liu G, Li Y, Pan Y (2022) Metabolic reprogramming induces macrophage polarization in the tumor microenvironment. Front Immunol. https://doi.org/10.3389/fimmu.2022.840029
doi: 10.3389/fimmu.2022.840029
pubmed: 36865525
pmcid: 9835811
Warner S, Auger K, Libby P (1987) Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. J Immunol 139(6):1911–1917
pubmed: 3497983
doi: 10.4049/jimmunol.139.6.1911
Webb BA, Forouhar F, Szu F-E, Seetharaman J, Tong L, Barber DL (2015) Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations. Nature 523(7558):111–114
pubmed: 25985179
pmcid: 4510984
doi: 10.1038/nature14405
Welch DR, Hurst DR (2019) Defining the hallmarks of metastasis. Can Res 79(12):3011–3027
doi: 10.1158/0008-5472.CAN-19-0458
Weljie AM, Jirik FR (2011) Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect. Int J Biochem Cell Biol 43(7):981–989
pubmed: 20797448
doi: 10.1016/j.biocel.2010.08.009
Yang H-L, Hseu Y-C, Chen J-Y et al (2006) Antrodia camphorata in submerged culture protects low density lipoproteins against oxidative modification. Am J Chin Med 34(02):217–231
pubmed: 16552834
doi: 10.1142/S0192415X06003783
Yang J-S, Gad H, Lee SY et al (2008a) A role for phosphatidic acid in COPI vesicle fission yields insights into Golgi maintenance. Nat Cell Biol 10(10):1146–1153
pubmed: 18776900
pmcid: 2756218
doi: 10.1038/ncb1774
Yang M-H, Wu M-Z, Chiou S-H et al (2008b) Direct regulation of TWIST by HIF-1α promotes metastasis. Nat Cell Biol 10(3):295–305
pubmed: 18297062
doi: 10.1038/ncb1691
Yang H-L, Kuo Y-H, Tsai C-T et al (2011) Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway. Food Chem Toxicol 49(1):290–298
pubmed: 21056076
doi: 10.1016/j.fct.2010.10.031
Yang H-L, Korivi M, Lin M-W, Chen S-C, Chou C-W, Hseu Y-C (2015) Anti-angiogenic properties of coenzyme Q0 through downregulation of MMP-9/NF-κB and upregulation of HO-1 signaling in TNF-α-activated human endothelial cells. Biochem Pharmacol 98(1):144–156
pubmed: 26348871
doi: 10.1016/j.bcp.2015.09.003
Yang S-w, Zhang Z-g, Hao Y-x et al (2017) HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway. Oncotarget 8(6):9535
pubmed: 28076840
pmcid: 5354751
doi: 10.18632/oncotarget.14484
Yang H-L, Thiyagarajan V, Shen P-C et al (2019a) Anti-EMT properties of CoQ
doi: 10.1186/s13046-019-1196-x
Yang Q, Liu R, Yu Q, Bi Y, Liu G (2019b) Metabolic regulation of inflammasomes in inflammation. Immunology 157(2):95–109
pubmed: 30851192
pmcid: 6526672
doi: 10.1111/imm.13056
Yang H-L, Tsai C-H, Shrestha S, Lee C-C, Liao J-W, Hseu Y-C (2021) Coenzyme Q
pubmed: 34229024
doi: 10.1016/j.fct.2021.112384
Yang R, Li Y, Wang H, Qin T, Yin X, Ma X (2022) Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy. Mol Biomed 3(1):1–18
pubmed: 34984525
pmcid: 8727650
doi: 10.1186/s43556-021-00063-y
Yoshida GJ (2015) Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J Exp Clin Cancer Res 34(1):1–10
doi: 10.1186/s13046-015-0221-y
Youm Y-H, Nguyen KY, Grant RW et al (2015) The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease. Nat Med 21(3):263–269
pubmed: 25686106
pmcid: 4352123
doi: 10.1038/nm.3804
Zahid A, Li B, Kombe AJK, Jin T, Tao J (2019) Pharmacological inhibitors of the NLRP3 inflammasome. Front Immunol 10:2538
pubmed: 31749805
pmcid: 6842943
doi: 10.3389/fimmu.2019.02538
Zahra K, Dey T, Mishra SP, Pandey U (2020) Pyruvate kinase M2 and cancer: the role of PKM2 in promoting tumorigenesis. Front Oncol 10:159
pubmed: 32195169
pmcid: 7061896
doi: 10.3389/fonc.2020.00159
Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469(7329):221–225. https://doi.org/10.1038/nature09663
doi: 10.1038/nature09663
pubmed: 21124315